visualizations
Holloway, Robert W., MD
Overview
overview
- Dr. Robert W. Holloway, MD is a board-certified gynecology oncologist in Orlando. Dr. Holloway joined the Florida Hospital Cancer Institute in 1994, and serves as the medical director of the Gynecologic Oncology Program. A graduate of Vanderbilt University School of Medicine, Dr. Holloway completed his OB/GYN residency at the University of Alabama at Birmingham and his fellowship in gynecologic oncology at Georgetown University in Washington, DC. Dr. Holloway is a Fellow of the American College of Surgeons. Additionally, Dr. Holloway is the principal investigator for several clinical trials and lectures regularly both nationally and internationally. His major research interests are robotic surgery and novel ovarian cancer therapies. Surgeons from around the world routinely attend his advanced training programs in robotic surgery.
research areas
- Biochemistry & Molecular Biology
- Biotechnology & Applied Microbiology
- Business & Economics
- Cell Biology
- General & Internal Medicine
- Genetics & Heredity
- Health Care Sciences & Services
- Hematology
- Infectious Diseases
- Nursing
- Obstetrics & Gynecology
- Oncology
- Pathology
- Pharmacology & Pharmacy
- Research & Experimental Medicine
- Surgery
Affiliation
Member of
-
Clinical Program
-
Research Department
Publications
Most Recent Publications
-
2024Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 34:977-984.Full Text via DOI: 10.1136/ijgc-2024-005402 PMID: 38830645
-
2024Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer. CANCER. 130:1940-1951.Full Text via DOI: 10.1002/cncr.35222 PMID: 38288862
-
2024Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies. GYNECOLOGIC ONCOLOGY. 182:63-69.Full Text via DOI: 10.1016/j.ygyno.2023.12.025 PMID: 38262240
-
2023Standardized Titration Protocol Reduces the Incidence of Paclitaxel Infusion-Related Hypersensitivity Reactions. JCO ONCOLOGY PRACTICE. 19:1199-+.Full Text via DOI: 10.1200/OP.23.00225 PMID: 37906723
-
2023Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulation. LIFE SCIENCES.Full Text via DOI: 10.1016/j.lfs.2023.122178 PMID: 37839778
-
2023Efficacy and safety of avutometinib plus defactinib in recurrent low-grade serous ovarian cancer following prior systemic therapy. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A3-A4.Full Text via DOI: 10.1136/ijgc-2023-IGCS.4
-
2023Management of immune-related adverse events in patients with primary advanced or recurrent endometrial cancer: dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A50-A51.Full Text via DOI: 10.1136/ijgc-2023-IGCS.80
-
2023Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032). GYNECOLOGIC ONCOLOGY. 178:161-169.Full Text via DOI: 10.1016/j.ygyno.2023.10.005 PMID: 37890345
-
2023Patient-reported outcomes (PROs) in patients (pts) with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer (pA/rEC) in the ENGOT-EN6-NSGO/GOG3031/RUBY trial. ANNALS OF ONCOLOGY. S513-S514.Full Text via DOI: 10.1016/j.annonc.2023.09.1928
-
2023Clinical outcomes analysis of neoadjuvant chemotherapy for locally advanced vulvar cancer. GYNECOLOGIC ONCOLOGY. S97-S97.Full Text via DOI: 10.1016/j.ygyno.2023.06.055
-
2023Immunotherapy response monitoring using personalized circulating tumor DNA analysis in patients with relapsed gynecologic malignancies. GYNECOLOGIC ONCOLOGY. S313-S314.Full Text via DOI: 10.1016/j.ygyno.2023.06.415
-
2023Post-surgical ctDNA-based molecular residual disease detection in patients with stage I endometrial cancer. GYNECOLOGIC ONCOLOGY. S8-S9.Full Text via DOI: 10.1016/j.ygyno.2023.06.476
-
2023A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 33:1458-1463.Full Text via DOI: 10.1136/ijgc-2023-004812 PMID: 37666539
-
2023Analysis of "sandwich" chemo-radiation therapy for stage IIIC endometrial cancer. GYNECOLOGIC ONCOLOGY. S143-S143.Full Text via DOI: 10.1016/j.ygyno.2023.06.132
-
2023Malignant peritoneal cytologic contamination with robotic hysterectomy for endometrial cancer. GYNECOLOGIC ONCOLOGY. 175:93-96.Full Text via DOI: 10.1016/j.ygyno.2023.06.006 PMID: 37329874
-
2023Clinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer The Nonrandomized Phase 2 VIRO-15 Clinical Trial. JAMA ONCOLOGY. 9:903-908.Full Text via DOI: 10.1001/jamaoncol.2023.1007 PMID: 37227734
-
2023Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma. GYNECOLOGIC ONCOLOGY. 169:164-171.Full Text via DOI: 10.1016/j.ygyno.2022.10.020 PMID: 36333181
-
2022A PHASE I/II STUDY EVALUATING INTRAPERITONEAL GEN-1 IN COMBINATION WITH NEOADJUVANT CHEMOTHERAPY IN PATIENTS NEWLY DIAGNOSED WITH ADVANCED EPITHELIAL OVARIAN CANCER. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A234-A234.Full Text via DOI: 10.1136/ijgc-2022-igcs.531
-
2022Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma. GYNECOLOGIC ONCOLOGY. 167:404-413.Full Text via DOI: 10.1016/j.ygyno.2022.08.021 PMID: 36273926
-
2022MALIGNANT PERITONEAL CYTOLOGIC CONTAMINATION WITH ROBOTIC HYSTERECTOMY FOR ENDOMETRIAL CANCER. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A93-A93.Full Text via DOI: 10.1136/ijgc-2022-igcs.204
-
2022OVERALL SURVIVAL RESULTS FROM ARIEL3: A PHASE 3 RANDOMIZED, DOUBLE-BLIND STUDY OF RUCAPARIB VS PLACEBO FOLLOWING RESPONSE TO PLATINUM-BASED CHEMOTHERAPY FOR RECURRENT OVARIAN CARCINOMA. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A3-A5.Full Text via DOI: 10.1136/ijgc-2022-igcs.5
-
2022PHASE 3 STUDY OF EFFICACY & SAFETY OF OLVI-VEC AND PLATINUM-DOUBLET plus BEVACIZUMAB COMPARED TO PLATINUM-DOUBLET plus BEVACIZUMAB IN PLATINUM-RESISTANT/REFRACTORY OVARIAN CANCER (ONPRIME; GOG-3076) [NCT05281471]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A236-A236.Full Text via DOI: 10.1136/ijgc-2022-igcs.535
-
2022Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy. GYNECOLOGIC ONCOLOGY. 167:306-313.Full Text via DOI: 10.1016/j.ygyno.2022.09.022 PMID: 36229265
-
2022The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis. JOURNAL OF GYNECOLOGIC ONCOLOGY.Full Text via DOI: 10.3802/jgo.2022.33.e66 PMID: 35882605
-
2022Corrigendum to "A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer" [Gynecologic Oncology 163 (2021) 481-489].. Gynecologic oncology. 401.Full Text via DOI: 10.1016/j.ygyno.2022.02.014 PMID: 35219528
-
2022Multidisciplinary approach to pelvic leiomyomatosis with intracaval and intracardiac extension: A case report and review of the literature. GYNECOLOGIC ONCOLOGY REPORTS.Full Text via DOI: 10.1016/j.gore.2022.100946 PMID: 35265743
-
2022Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives. ONCOTARGETS AND THERAPY. 853-866.Full Text via DOI: 10.2147/OTT.S335936 PMID: 35982728
-
2021A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer. GYNECOLOGIC ONCOLOGY. 163:481-489.Full Text via DOI: 10.1016/j.ygyno.2021.10.069 PMID: 34686353
-
2021Predicted Immunogenicity of CDK12 Biallelic Loss-of-Function Tumors Varies across Cancer Types. JOURNAL OF MOLECULAR DIAGNOSTICS. 23:1761-1773.Full Text via DOI: 10.1016/j.jmoldx.2021.08.010 PMID: 34562615
-
2021ASO Visual Abstract: Carcinomatosis in Early-Stage Cervical Cancer Treated with Robotic Radical Hysterectomy-Recurrence Patterns, Risk Factors, and Survival. ANNALS OF SURGICAL ONCOLOGY.Full Text via DOI: 10.1245/s10434-021-11148-x PMID: 34850304
-
2021Carcinomatosis in Early-Stage Cervical Cancer Treated with Robotic Radical Hysterectomy: Recurrence Patterns, Risk Factors, and Survival. ANNALS OF SURGICAL ONCOLOGY.Full Text via DOI: 10.1245/s10434-021-11052-4 PMID: 34757549
-
2021Assessment of immune biomarkers and establishing a triple negative phenotype in gynecologic cancers. GYNECOLOGIC ONCOLOGY. 163:312-319.Full Text via DOI: 10.1016/j.ygyno.2021.09.011 PMID: 34563366
-
2021CLINICAL AND MOLECULAR CHARACTERISTICS OF ARIEL3 PATIENTS WHO DERIVED EXCEPTIONAL BENEFIT FROM RUCAPARIB MAINTENANCE TREATMENT FOR HIGH-GRADE OVARIAN CANCER (HGOC). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A10-A10.Full Text via DOI: 10.1136/ijgc-2021-IGCS.16
-
2021Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 367-+.Full Text via DOI: 10.1016/j.ajog.2021.05.034 PMID: 34058168
-
2021Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety. CANCER MEDICINE. 10:7162-7173.Full Text via DOI: 10.1002/cam4.4260 PMID: 34549539
-
2021Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives. GYNECOLOGIC ONCOLOGY. 809-815.Full Text via DOI: 10.1016/j.ygyno.2021.06.006 PMID: 34130862
-
2021FOXL2 mutation is prevalent in metastatic adult granulosa cell tumors and is associated with improved survival. GYNECOLOGIC ONCOLOGY. S162-S163.
-
2021Transcriptomic immune profiling: a precision path forward for immunotherapy in patients with cervical cancer?. GYNECOLOGIC ONCOLOGY. S13-S13.
-
2021Intratubal Pseudopapillary Histiocytic Hyperplasia: A New Histologic Variant in the Spectrum of Histiocytic Lesions Involving the Fallopian Tube. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY. 40:369-375.Full Text via DOI: 10.1097/PGP.0000000000000740 PMID: 33323856
-
2021Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 31:949-958.Full Text via DOI: 10.1136/ijgc-2020-002240 PMID: 34103386
-
2021Feasibility of a telemedicine lifestyle-based rehabilitation program (HEAL) for gynecologic cancer patients.. JOURNAL OF CLINICAL ONCOLOGY.Full Text via DOI: 10.1200/JCO.2021.39.15_suppl.e24033
-
2021Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?. GYNECOLOGIC ONCOLOGY. 161:347-352.Full Text via DOI: 10.1016/j.ygyno.2021.02.017 PMID: 33678480
-
2021The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY.Full Text via DOI: 10.1016/j.critrevonc.2020.103165 PMID: 33227575
-
2020FREQUENCY AND MOLECULAR ASSOCIATIONS OF KRAS MUTATIONS IN GYNECOLOGIC MALIGNANCIES. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A158-A159.
-
2020KRAS MUTANT UTERINE CARCINOMAS. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A174-A174.
-
2020ONCOLYTIC VACCINIA (OLVI-VEC) PRIMED IMMUNOCHEMOTHERAPY IN PLATINUM-RESISTANT/REFRACTORY OVARIAN CANCER. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A9-A10.Full Text via DOI: 10.1136/ijgc-2020-IGCS.12
-
2020POSTPROGRESSION EFFICACY OUTCOMES FROM THE PHASE 3 ARIEL3 STUDY OF RUCAPARIB IN PATIENTS WITH PLATINUM-SENSITIVE RECURRENT OVARIAN CARCINOMA ASSOCIATED WITH EITHER BRCA1 OR BRCA2 MUTATIONS. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A2-A3.Full Text via DOI: 10.1136/ijgc-2020-IGCS.3
-
2020Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?. GYNECOLOGIC ONCOLOGY. 159:354-358.Full Text via DOI: 10.1016/j.ygyno.2020.08.004 PMID: 32888724
-
2020Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma. JOURNAL OF CLINICAL ONCOLOGY. 38:3494-+.Full Text via DOI: 10.1200/JCO.19.03107 PMID: 32840418
-
2020Phase II VIRO-15 trial of olvimulogene nanivacirepvec (Olvi-Vec)-primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588). GYNECOLOGIC ONCOLOGY. 60-60.Full Text via DOI: 10.1016/j.ygyno.2020.06.126
-
2020Postprogression outcomes in patients with ovarian carcinoma associated with amutation in a non-BRCA homologous recombination repair gene receiving rucaparib maintenance treatment: Results from the phase III study ARIEL3. GYNECOLOGIC ONCOLOGY. 74-75.Full Text via DOI: 10.1016/j.ygyno.2020.06.153
-
2020Robotic-assisted laparoscopic splenectomy in recurrent ovarian cancer: A case series with clinical outcomes. GYNECOLOGIC ONCOLOGY. 132-132.Full Text via DOI: 10.1016/j.ygyno.2020.05.166
-
2020The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma. GYNECOLOGIC ONCOLOGY. 159:101-111.Full Text via DOI: 10.1016/j.ygyno.2020.05.045 PMID: 32861537
-
2020The effect of intraperitoneal chemotherapy after interval cytoreductive surgery on recurrence and survival in patients with advanced-stage ovarian carcinoma. GYNECOLOGIC ONCOLOGY. 154-154.Full Text via DOI: 10.1016/j.ygyno.2020.05.219
-
2020KRAS mutant epithelial ovarian carcinomas (EOC) represent distinct genomic genotypes. ANNALS OF ONCOLOGY. S632-S632.Full Text via DOI: 10.1016/j.annonc.2020.08.983
-
2020Phase II trial of oncolytic vaccinia virus primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588). ANNALS OF ONCOLOGY. S628-S628.Full Text via DOI: 10.1016/j.annonc.2020.08.976
-
2020Timing of adverse events during maintenance treatment with rucaparib for recurrent ovarian cancer in the phase III ARIEL3 study. ANNALS OF ONCOLOGY. S620-S621.Full Text via DOI: 10.1016/j.annonc.2020.08.960
-
2020Robotic-assisted laparoscopic splenectomy for recurrent ovarian cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 30:1189-1194.Full Text via DOI: 10.1136/ijgc-2020-001384 PMID: 32624496
-
2020Clinicopathologic analysis of MMR gene mutations and uterine adenocarcinomas: An updated population-based study.. JOURNAL OF CLINICAL ONCOLOGY.
-
2020
-
2020Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study. JOURNAL OF CLINICAL ONCOLOGY. 38:1030-+.Full Text via DOI: 10.1200/JCO.19.03012 PMID: 32031867
-
2020Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study. GYNECOLOGIC ONCOLOGY. 156:523-529.Full Text via DOI: 10.1016/j.ygyno.2019.12.024 PMID: 31916979
-
2020Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 30:305-310.Full Text via DOI: 10.1136/ijgc-2019-000915 PMID: 31857439
-
2020Widespread choriocarcinoma metastases from de-differentiated gastro-esophageal junction primary adenocarcinoma: A case report with literature review. GYNECOLOGIC ONCOLOGY REPORTS.Full Text via DOI: 10.1016/j.gore.2019.100513 PMID: 31886402
-
2019A prospective randomized trial of intravenous ketorolac vs. acetaminophen administered with opioid patient-controlled analgesia in gynecologic surgery. GYNECOLOGIC ONCOLOGY. 155:468-472.Full Text via DOI: 10.1016/j.ygyno.2019.09.019 PMID: 31601494
-
2019EFFECT OF PROGRESSION-FREE INTERVAL (PFI) FOLLOWING PENULTIMATE PLATINUM-BASED REGIMEN ON THE EFFICACY OF RUCAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH PLATINUM-SENSITIVE, RECURRENT OVARIAN CARCINOMA: AN ANALYSIS FROM THE PHASE 3 STUDY ARIEL3. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A27-A28.Full Text via DOI: 10.1136/ijgc-2019-ESGO.28
-
2019PATIENT-CENTRED OUTCOMES IN THE PHASE 3 STUDY ARIEL3 OF RUCAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH PLATINUM-SENSITIVE, RECURRENT OVARIAN CARCINOMA: POST HOC EXPLORATORY ANALYSES BY BRCA MUTATION STATUS AND PATIENT AGE. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A28-A29.Full Text via DOI: 10.1136/ijgc-2019-ESGO.29
-
2019A PHASE IB STUDY OF INDIRECT IMMUNIZATION WITH OREGOVOMAB AND TLR3 STIMULATION WITH HILTONOL (R) (H) IN PATIENTS WITH RECURRENT PLATINUM RESISTANT OVARIAN CANCER (PROC). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A126-A126.Full Text via DOI: 10.1136/ijgc-2019-IGCS.302
-
2019EXPLORATORY ANALYSIS OF POSTPROGRESSION AND PATIENT-CENTERED OUTCOMES IN ARIEL3: A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RUCAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH RECURRENT OVARIAN CARCINOMA. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A1-A2.Full Text via DOI: 10.1136/ijgc-2019-IGCS.2
-
2019FACTORS ASSOCIATED WITH EXTENDED SURVIVAL FOR PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER (PROC) TREATED WITH MODIFIED VACCINIA ONCOLYTIC VIROTHERAPY (VOV). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A58-A58.Full Text via DOI: 10.1136/ijgc-2019-IGCS.120
-
2019Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma. JAMA ONCOLOGY. 5:1141-1149.Full Text via DOI: 10.1001/jamaoncol.2019.1048 PMID: 31194228
-
2019Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis. GYNECOLOGIC ONCOLOGY. 154:53-59.Full Text via DOI: 10.1016/j.ygyno.2019.04.654 PMID: 31027899
-
2019Comprehensive genomic profiling of mucinous ovarian carcinoma with comparisons to mucinous colorectal carcinoma. GYNECOLOGIC ONCOLOGY. 63-63.Full Text via DOI: 10.1016/j.ygyno.2019.04.149
-
2019Comprehensive molecular profiles of low-grade serous ovarian carcinoma. GYNECOLOGIC ONCOLOGY. 60-61.Full Text via DOI: 10.1016/j.ygyno.2019.04.144
-
2019Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma. GYNECOLOGIC ONCOLOGY. 175-175.Full Text via DOI: 10.1016/j.ygyno.2019.04.407
-
2019Post hoc exploratory analysis of rucaparib in patients with platinum-sensitive recurrent ovarian carcinoma from the randomized, placebo-controlled phase III study ARIEL3: Effect of a deleterious germline or no germline BRCA mutation on efficacy. GYNECOLOGIC ONCOLOGY. 237-237.Full Text via DOI: 10.1016/j.ygyno.2019.04.549
-
2019Timing of postoperative Foley catheter removal fromrobotic-assisted radical hysterectomy in patients with early-stage cervical cancer. GYNECOLOGIC ONCOLOGY. 157-157.Full Text via DOI: 10.1016/j.ygyno.2019.04.369
-
2019Association betweenBRCA1 and BRCA2 mutations and prognosis in women with endometrial carcinoma.. JOURNAL OF CLINICAL ONCOLOGY.
-
2019
-
2018Use of the Poly (ADP-Ribose) Polymerase Inhibitor Rucaparib in Women with Recurrent Ovarian Carcinoma with Endometrioid and Other Nonserous Histopathologic Subtypes. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 200-201.
-
2018EFFECT OF PRIOR BEVACIZUMAB THERAPY IN PATIENTS WITH PLATINUM-SENSITIVE RECURRENT OVARIAN CARCINOMA (ROC) IN THE PHASE 3 STUDY ARIEL3. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 45-46.
-
2018Poorly differentiated, ovarian Sertoli-Leydig cell tumor with heterologous rhabdomyosarcoma and glandular elements: Diagnosis and management of a rare neoplasm. GYNECOLOGIC ONCOLOGY REPORTS. 25:70-73.Full Text via DOI: 10.1016/j.gore.2018.06.003 PMID: 29922708
-
2018Learning Needs of Women Who Undergo Robotic Versus Open Gynecologic Surgery. JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING. 47:490-497.Full Text via DOI: 10.1016/j.jogn.2018.04.133 PMID: 29750905
-
2018Poster Session Paraaortic lymph node dissection pathology in patients with endometrial cancer undergoing robotic sentinel lymph node mapping (SLNM). GYNECOLOGIC ONCOLOGY. 109-109.Full Text via DOI: 10.1016/j.ygyno.2018.04.252
-
2018Recurrence patterns and survival in patients with endometrial cancer undergoing robotic sentinel lymph node mapping (SLNM). GYNECOLOGIC ONCOLOGY. 108-108.Full Text via DOI: 10.1016/j.ygyno.2018.04.249
-
2018Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?. GYNECOLOGIC ONCOLOGY. 7-8.Full Text via DOI: 10.1016/j.ygyno.2018.04.024
-
2018Topacio: Preliminary activity and safety in patients (pts) with platinum-resistant ovarian cancer (PROC) in a phase 1/2 study of niraparib in combination with pembrolizumab. GYNECOLOGIC ONCOLOGY. 246-246.Full Text via DOI: 10.1016/j.ygyno.2018.04.554
-
2018Phase 1b study of oncolytic vaccinia virus GL-ONC1 in recurrent ovarian cancer (ROC).. JOURNAL OF CLINICAL ONCOLOGY.
-
2017ARIEL3: PHASE 3, RANDOMISED, DOUBLE-BLIND STUDY OF RUCAPARIB VS PLACEBO FOLLOWING RESPONSE TO PLATINUM-BASED CHEMOTHERAPY FOR RECURRENT OVARIAN CARCINOMA (OC). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 10-11.
-
2017ARIEL3: PHASE 3, RANDOMISED, DOUBLE-BLIND STUDY OF RUCAPARIB VS PLACEBO FOLLOWING RESPONSE TO PLATINUM-BASED CHEMOTHERAPY FOR RECURRENT OVARIAN CARCINOMA (OC). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 1972-1973.
-
2017Indications and techniques for robotic pelvic and para-aortic lymphadenectomy with sentinel lymph. node mapping in gynecologic oncology. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY. 45:83-93.Full Text via DOI: 10.1016/j.bpobgyn.2017.04.006 PMID: 28533155
-
2017Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. LANCET. 390:1949-1961.Full Text via DOI: 10.1016/S0140-6736(17)32440-6 PMID: 28916367
-
2017Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. GYNECOLOGIC ONCOLOGY. 405-415.Full Text via DOI: 10.1016/j.ygyno.2017.05.027 PMID: 28566221
-
2017A Prospective Cohort Study Comparing Colorimetric and Fluorescent Imaging for Sentinel Lymph Node Mapping in Endometrial Cancer. ANNALS OF SURGICAL ONCOLOGY. 24:1972-1979.Full Text via DOI: 10.1245/s10434-017-5825-3 PMID: 28265777
-
2017Patient care needs before and after robotic surgery for gynecologic cases in comparison to laparotomy. GYNECOLOGIC ONCOLOGY. 201-201.Full Text via DOI: 10.1016/j.ygyno.2017.03.462
-
2016Role of Gamma Knife (R) Radiosurgery for the Treatment of Brain Metastases from Gynecological Cancers. CUREUS. 8.Full Text via DOI: 10.7759/cureus.947 PMID: 28168125
-
2016Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly A Retrospective Cohort. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 26:1717-1721.Full Text via DOI: 10.1097/IGC.0000000000000822 PMID: 27575633
-
2016Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation. TUMOR BIOLOGY. 37:14259-14269.Full Text via DOI: 10.1007/s13277-016-5290-9 PMID: 27581819
-
2016Cardiac Arrest in Acute Ischemic Stroke: Incidence, Predisposing Factors, and Clinical Outcomes. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. 25:1644-1652.Full Text via DOI: 10.1016/j.jstrokecerebrovasdis.2016.03.010 PMID: 27067880
-
2016Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis. GYNECOLOGIC ONCOLOGY. 141:206-210.Full Text via DOI: 10.1016/j.ygyno.2016.02.018 PMID: 26905211
-
2016Robot-assisted versus open radical hysterectomy: A multi-institutional experience for early-stage cervical cancer. EJSO. 42:513-522.Full Text via DOI: 10.1016/j.ejso.2015.12.014 PMID: 26843445
-
2015Indications and Techniques for Robotic Pelvic and Para-Aortic Lymphadenectomy in Gynecologic Oncology. JOURNAL OF SURGICAL ONCOLOGY. 782-789.Full Text via DOI: 10.1002/jso.24005 PMID: 26288990
-
2015Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancer. MOLECULAR AND CELLULAR BIOCHEMISTRY. 407:281-287.Full Text via DOI: 10.1007/s11010-015-2475-2 PMID: 26048718
-
2015Impact of sentinel lymph node mapping on FIGO stage and GOG risk stratification in early endometrial cancer: A comparative analysis. GYNECOLOGIC ONCOLOGY. 21-22.Full Text via DOI: 10.1016/j.ygyno.2015.01.050
-
2015Robotic versus Open Type III radical hysterectomy: A multi-institutional experience for early stage cervical cancer. GYNECOLOGIC ONCOLOGY. 10-10.Full Text via DOI: 10.1016/j.ygyno.2015.01.021
-
2015Robotically Assisted Para-aortic Lymphadenectomy: Surgical Results A Cohort Study of 487 Patients. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 25:504-511.Full Text via DOI: 10.1097/IGC.0000000000000373 PMID: 25628104
-
2015Robotic transperitoneal infra-renal aortic lymphadenectomy in early-stage endometrial cancer. GYNECOLOGIC ONCOLOGY. 136:285-292.Full Text via DOI: 10.1016/j.ygyno.2014.12.028 PMID: 25546115
-
2015Robotic-assisted Laparoscopic Resection of Cornual Ectopic Pregnancy A Case Report. JOURNAL OF REPRODUCTIVE MEDICINE. 60:58-64.PMID: 25745753
-
2014Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer A Phase II Study. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 24:1583-1589.Full Text via DOI: 10.1097/IGC.0000000000000286 PMID: 25254563
-
2014Relevance of Sp1 and survivin expression in epithelial ovarian cancer patients and their usefulness as potential therapeutic targets. CANCER RESEARCH.Full Text via DOI: 10.1158/1538-7445.AM2014-1354
-
2014Overview of a chemoresponse assay in ovarian cancer. CLINICAL & TRANSLATIONAL ONCOLOGY. 16:761-769.Full Text via DOI: 10.1007/s12094-014-1192-8 PMID: 24986099
-
2014Pelvic sentinel lymph node status and risk of aortic nodal metastasis in patients with endometrial cancer.. JOURNAL OF CLINICAL ONCOLOGY.
-
2013A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer. GYNECOLOGIC ONCOLOGY. 131:362-367.Full Text via DOI: 10.1016/j.ygyno.2013.08.009 PMID: 23954900
-
2013A comparison of patient outcomes in advanced ovarian cancer: Assay-informed vs. empirically treated. CLINICAL CANCER RESEARCH.Full Text via DOI: 10.1158/1078-0432.OVCA13-A85
-
2013A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian cancer. GYNECOLOGIC ONCOLOGY. 276-276.Full Text via DOI: 10.1016/j.ygyno.2013.07.077
-
2013ROBOTICALLY-ASSISTED PARA-AORTIC LYMPHADENECTOMY: SURGICAL RESULTS - A COHORT STUDY OF 487 PATIENTS. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER.
-
2013Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO-The MIMOSA Study. JOURNAL OF CLINICAL ONCOLOGY. 31:1554-1561.Full Text via DOI: 10.1200/JCO.2012.46.4057 PMID: 23478059
-
2013Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial. BRITISH JOURNAL OF CANCER. 108:1021-1026.Full Text via DOI: 10.1038/bjc.2013.59 PMID: 23403817
-
2013Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgery. GYNECOLOGIC ONCOLOGY. 128:309-315.Full Text via DOI: 10.1016/j.ygyno.2012.11.005 PMID: 23153590
-
2013A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer. GYNECOLOGIC ONCOLOGY. 128:65-70.Full Text via DOI: 10.1016/j.ygyno.2012.10.010 PMID: 23085460
-
2013Primary peritoneal low-grade serous carcinoma forming a mass in the colon mimicking a colonic primary carcinoma: a case report. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. 34:86-89.PMID: 23590009
-
2012A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission. CLINICAL CANCER RESEARCH. 18:6509-6518.Full Text via DOI: 10.1158/1078-0432.CCR-12-1796 PMID: 23032746
-
2012Peri-operative outcomes of patients with stage IV endometriosis undergoing robotic-assisted laparoscopic surgery. JOURNAL OF ROBOTIC SURGERY. 6:317-322.Full Text via DOI: 10.1007/s11701-011-0314-3 PMID: 27628471
-
2012Does a uterine manipulator affect cervical cancer pathology or identification of lymphovascular space involvement?. GYNECOLOGIC ONCOLOGY. 127:98-101.Full Text via DOI: 10.1016/j.ygyno.2012.07.094 PMID: 22800652
-
2012Chemoradiation with adjuvant hysterectomy for stage IB-2 cervical cancer: a 10-year experience. GYNECOLOGICAL SURGERY. 9:327-333.Full Text via DOI: 10.1007/s10397-011-0717-1
-
2012Metastatic Leiomyosarcoma of the Uterus With Heterologous Differentiation to Malignant Mesenchymoma. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY. 31:453-457.Full Text via DOI: 10.1097/PGP.0b013e318246977d PMID: 22833086
-
2012Cellular Therapy for Ovarian Cancer: Experimental and Clinical Perspectives. CURRENT MEDICINAL CHEMISTRY. 3787-3793.PMID: 22680925
-
2012A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. CANCER. 118:3283-3293.Full Text via DOI: 10.1002/cncr.26610 PMID: 22072307
-
2012Comparison of the cytotoxic response against ovarian cancer by immune effector cells isolated and expanded from normal donors and ovarian cancer patients. CYTOTHERAPY. 14:716-723.Full Text via DOI: 10.3109/14653249.2012.663484 PMID: 22409787
-
2012Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: A comparison of colorimetric and fluorescence imaging. GYNECOLOGIC ONCOLOGY. 126:25-29.Full Text via DOI: 10.1016/j.ygyno.2012.04.009 PMID: 22507531
-
2012Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging. GYNECOLOGIC ONCOLOGY. 125:546-551.Full Text via DOI: 10.1016/j.ygyno.2012.02.023 PMID: 22387522
-
2012Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells. ONCOGENE. 31:2309-2322.Full Text via DOI: 10.1038/onc.2011.409 PMID: 21909139
-
2012Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancer. CANCER RESEARCH.Full Text via DOI: 10.1158/1538-7445.AM2012-3518
-
2012Targeting Sp1 and survivin for potential ovarian cancer therapy: Comparative assessment of anti-cancer NSAID tolfenamic acid and cisplatin. CANCER RESEARCH.Full Text via DOI: 10.1158/1538-7445.AM2012-4656
-
2012An assessment of robotic transperitoneal infra-renal aortic lymphadenectomy in early endometrial carcinoma. GYNECOLOGIC ONCOLOGY. S157-S157.Full Text via DOI: 10.1016/j.ygyno.2011.12.387
-
2012Analysis of recurrence and survival following abdominal radical hysterectomy for cervical cancer in the era of GOG Sedlis criteria. GYNECOLOGIC ONCOLOGY. S56-S57.Full Text via DOI: 10.1016/j.ygyno.2011.12.136
-
2012Detection of sentinel lymph nodes in patients with endometrial cancer undergoing robotic-assisted staging: A comparison of colorimetric and fluorescence imaging. GYNECOLOGIC ONCOLOGY. S19-S19.Full Text via DOI: 10.1016/j.ygyno.2011.12.046
-
2012Endometrial cancer staging in the elderly: Robotic or open?. GYNECOLOGIC ONCOLOGY. S149-S149.Full Text via DOI: 10.1016/j.ygyno.2011.12.365
-
2012Pre-clinical models of cellular therapy combined with cytokines demonstrate in vitro and in vivo ovarian cancer cell killing. GYNECOLOGIC ONCOLOGY. S45-S45.Full Text via DOI: 10.1016/j.ygyno.2011.12.105
-
2012Robotic-assisted surgery in gynecologic oncology: A Society of Gynecologic Oncology consensus statement Developed by the Society of Gynecologic Oncology's Clinical Practice Robotics Task Force. GYNECOLOGIC ONCOLOGY. 180-184.Full Text via DOI: 10.1016/j.ygyno.2011.11.006 PMID: 22079679
-
2012Robotic-assisted surgery in the management of endometrial cancer. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH. 38:1-8.Full Text via DOI: 10.1111/j.1447-0756.2011.01744.x PMID: 22136216
-
2012Use of pegylated liposomal doxorubicin in the management of platinum-sensitive recurrent ovarian cancer: current concepts. EXPERT REVIEW OF ANTICANCER THERAPY. 31-40.Full Text via DOI: 10.1586/ERA.11.187 PMID: 22149430
-
2011Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: Results from a randomized clinical trial. GYNECOLOGIC ONCOLOGY. 123:505-510.Full Text via DOI: 10.1016/j.ygyno.2011.08.015 PMID: 21945310
-
2011Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors. GYNECOLOGIC ONCOLOGY. 122:163-170.Full Text via DOI: 10.1016/j.ygyno.2011.03.014 PMID: 21496890
-
2011Catumaxomab treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: A phase II study. JOURNAL OF CLINICAL ONCOLOGY.
-
2011A novel therapeutic compound, tolfenamic acid, inhibits ovarian cancer cell growth: Therapeutic implications. CANCER RESEARCH.Full Text via DOI: 10.1158/1538-7445.AM2011-2034
-
2011Functional characterization of a fluorescent highly tumorigenic ovarian cancer line to test cellular therapy in experimental models. CANCER RESEARCH.Full Text via DOI: 10.1158/1538-7445.AM2011-2708
-
2011Functional Characterization of a Fluorescent Highly Tumorigenic Ovarian Cancer Line to Test Cellular Therapy in Experimental Models. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 21:457-465.Full Text via DOI: 10.1097/IGC.0b013e31820f4ef0 PMID: 21430454
-
2011Does a uterine manipulator affect cervical cancer pathology or identification of lymphovascular space involvement?. GYNECOLOGIC ONCOLOGY. S27-S27.Full Text via DOI: 10.1016/j.ygyno.2010.12.067
-
2011Robotic-assisted resection of liver and diaphragm recurrent ovarian carcinoma: Description of technique. GYNECOLOGIC ONCOLOGY. 120:419-422.Full Text via DOI: 10.1016/j.ygyno.2010.09.007 PMID: 20943259
-
2011Short- and long-term morbidity and outcomes after robotic surgery for endometrial cancer staging. GYNECOLOGIC ONCOLOGY. S41-S41.Full Text via DOI: 10.1016/j.ygyno.2010.12.100
-
2011Survival outcomes for women with uterine malignancy undergoing robot-assisted laparoscopic staging procedures. GYNECOLOGIC ONCOLOGY. S95-S95.Full Text via DOI: 10.1016/j.ygyno.2010.12.226
-
2010Robotic-Assisted Hysterectomy for Endometrial Cancer Compared With Traditional Laparoscopic and Laparotomy Approaches A Systematic Review. OBSTETRICS AND GYNECOLOGY. 1422-1431.Full Text via DOI: 10.1097/AOG.0b013e3181f74153 PMID: 21099613
-
2010Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine-Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review. ONCOLOGIST. 1073-1082.Full Text via DOI: 10.1634/theoncologist.2009-0331 PMID: 20930103
-
2010Correlation of Extreme Drug Resistance Assay Results and Progression-Free Survival Following Intraperitoneal Chemotherapy for Advanced Ovarian Cancer. JOURNAL OF CHEMOTHERAPY. 22:270-274.PMID: 20685633
-
2010Chemoradiation followed by adjuvant hysterectomy for the treatment of stage IB-2 cervical cancer: 10-year experience. JOURNAL OF CLINICAL ONCOLOGY.
-
2010
-
2010The role of adjuvant therapy in women with optimally cytoreduced stage IIIC endometrial cancer. GYNECOLOGIC ONCOLOGY. S81-S81.
-
2010Extreme drug resistance assay does not influence survival in women with epithelial ovarian cancer. GYNECOLOGIC ONCOLOGY. 147-148.Full Text via DOI: 10.1016/j.ygyno.2009.08.027 PMID: 19767066
-
2010Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis.. Journal of palliative medicine. 59-65.Full Text via DOI: 10.1089/jpm.2009.0220 PMID: 19839739
-
2009Robotic-assisted laparoscopic hysterectomy and lymphadenectomy for endometrial cancer: Analysis of surgical performance. GYNECOLOGIC ONCOLOGY. 115:447-452.Full Text via DOI: 10.1016/j.ygyno.2009.08.017 PMID: 19765807
-
2009Emergence of robotic assisted surgery in gynecologic oncology: American perspective. GYNECOLOGIC ONCOLOGY. S24-S31.Full Text via DOI: 10.1016/j.ygyno.2009.02.002 PMID: 19573702
-
2009Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. GYNECOLOGIC ONCOLOGY. 113:21-27.Full Text via DOI: 10.1016/j.ygyno.2008.12.003 PMID: 19162309
-
2009Functional characterization of a fluorescent highly tumorigenic cell line to use in an animal model of ovarian cancer. GYNECOLOGIC ONCOLOGY. S104-S105.
-
2009Robotic assisted laparoscopic hysterectomy with lymphadenectomy for endometrial cancer: The learning curve and beyond. GYNECOLOGIC ONCOLOGY. S169-S170.
-
2009The use of extreme drug resistance assay in predicting success with intraperitoneal chemotherapy for advanced ovarian cancer. GYNECOLOGIC ONCOLOGY. S63-S63.
-
2009ROBOTIC SURGERY IN GYNECOLOGY. SCANDINAVIAN JOURNAL OF SURGERY. 96-109.PMID: 19799047
-
2009Synergistic cytotoxicity of interferon alpha-2b and interleukin-2 in combination with PBMC against ovarian cancer: Development of an experimental model for cellular therapy. GYNECOLOGIC ONCOLOGY. 112:192-198.Full Text via DOI: 10.1016/j.ygyno.2008.09.028 PMID: 18995891
-
2008Robotically assisted laparoscopic hysterectomy versus total abdominal hysterectomy and lymphadenectomy for endometrial cancer. GYNECOLOGIC ONCOLOGY. 111:412-417.Full Text via DOI: 10.1016/j.ygyno.2008.08.025 PMID: 18834620
-
2008Metastatic appendiceal mucinous adenocarcinoma to well-differentiated diffuse mesothelioma of the peritoneal cavity: A mimicker of florid mesothelial hyperplasia in association with neoplasms. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY. 27:526-530.Full Text via DOI: 10.1097/PGP.0b013e3181705792 PMID: 18753969
-
2008Robotically assisted laparoscopic hysterectomy versus total abdominal hysterectomy and lymphadenectomy for endometrial cancer. GYNECOLOGIC ONCOLOGY. S109-S109.
-
2007Clinical-pathologic and morbidity analyses of types 2 and 3 abdominal radical hysterectomy for cervical cancer. GYNECOLOGIC ONCOLOGY. 107:205-210.Full Text via DOI: 10.1016/j.ygyno.2007.06.015 PMID: 17692367
-
2007Comparison of total Laparoscopic and abdominal radical hysterectomy for patients with early-stage cervical cancer. OBSTETRICS AND GYNECOLOGY. 1174-1174.PMID: 17978141
-
2007Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: A case report and review of the literature. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY. 26:66-70.Full Text via DOI: 10.1097/01.pgp.0000225843.21503.30 PMID: 17197899
-
2006A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.. JOURNAL OF CLINICAL ONCOLOGY. 278S-278S.
-
2005Endometroid adenocarcinoma of the uterus with cardiac metastasis - A case report and six-year follow-up. GYNECOLOGIC ONCOLOGY. 97:256-259.Full Text via DOI: 10.1016/j.ygyno.2004.12.052 PMID: 15790471
-
2003A phase 11 study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer. GYNECOLOGIC ONCOLOGY. 91:318-325.Full Text via DOI: 10.1016/S0090-8258(03)00491-8 PMID: 14599861
-
2003Treatment options for endometrial cancer: experience with topotecan. GYNECOLOGIC ONCOLOGY. 90:S28-S33.Full Text via DOI: 10.1016/S0090-8258(03)00468-2 PMID: 13129493
-
2003Workshop: options for therapy in ovarian cancer. GYNECOLOGIC ONCOLOGY. 90:S45-S50.Full Text via DOI: 10.1016/S0090-8258(03)00473-6 PMID: 13129496
-
2002Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients. GYNECOLOGIC ONCOLOGY. 87:8-16.Full Text via DOI: 10.1006/gyno.2002.6797 PMID: 12468336
-
2002Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix. GYNECOLOGIC ONCOLOGY. 85:89-94.Full Text via DOI: 10.1006/gyno.2001.6557 PMID: 11925125
-
1995AN EVALUATION OF GROSHONG CENTRAL VENOUS CATHETERS ON A GYNECOLOGIC ONCOLOGY SERVICE. GYNECOLOGIC ONCOLOGY. 56:211-217.PMID: 7896188
-
1993Intra-abdominal malignancy.. GYNECOLOGIC ONCOLOGY. 407-8.PMID: 8314546
-
1992THE EFFICACY AND SAFETY OF THE CYTOBRUSH DURING PREGNANCY. GYNECOLOGIC ONCOLOGY. 44:260-262.PMID: 1541438
-
1991SURGICAL ASPECTS OF CERVICAL-CANCER. SURGICAL CLINICS OF NORTH AMERICA. 71:1067-1083.PMID: 1925852
-
1991SURGICAL STAGING OF UTERINE-CANCER - AN ANALYSIS OF PERIOPERATIVE MORBIDITY. GYNECOLOGIC ONCOLOGY. 42:209-216.PMID: 1955182
-
1991IDENTIFICATION OF HUMAN PAPILLOMAVIRUS TYPE-16 IN PRIMARY AND RECURRENT CERVICAL-CANCER FOLLOWING RADIATION-THERAPY. GYNECOLOGIC ONCOLOGY. 41:123-128.PMID: 1646755
-
1990THE USE OF INSITU HYBRIDIZATION TO SHOW HUMAN PAPILLOMAVIRUS DEOXYRIBONUCLEIC-ACID IN METASTATIC CANCER-CELLS WITHIN LYMPH-NODES. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 163:1333-1337.PMID: 2171342
-
1990
-
1989MONITORING THE COURSE OF CERVICAL-CARCINOMA WITH THE SQUAMOUS-CELL CARCINOMA SERUM RADIOIMMUNOASSAY. OBSTETRICS AND GYNECOLOGY. 74:944-949.PMID: 2586961
-
1988MELANOSIS OF THE CERVIX. GYNECOLOGIC ONCOLOGY. 29:101-104.PMID: 3338656
-
1987PSAMMOMA BODIES IN A CERVICOVAGINAL SMEAR ASSOCIATED WITH AN INTRAUTERINE-DEVICE - A CASE-REPORT. JOURNAL OF REPRODUCTIVE MEDICINE. 32:147-148.PMID: 3560079
Background
Full Name
- Robert W. Holloway, MD
Education
- Vanderbilt University Medical Center
Residency
- University of Alabama Birmingham
Fellowship
- Georgetown University Hospital
Board Certification
- American Board of Obstetrics & Gynecology
Contact
primary email
- Research.Institute@AdventHealth.com